Page last updated: 2024-12-11

chrysotoxine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chrysotoxine: inhibits 6-hydroxydopamine induced apoptosis in SH-SY5Y cells via mitochondria protection and NF-κB modulation; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5315860
CHEMBL ID219352
MeSH IDM0554237

Synonyms (8)

Synonym
chrysotoxine
CHEMBL219352
4-[2-(3,4-dimethoxyphenyl)ethyl]-2,6-dimethoxyphenol
phenol, 4-[2-(3,4-dimethoxyphenyl)ethyl]-2,6-dimethoxy-
156951-82-5
DTXSID20415692
AKOS028111782
4-(3,4-dimethoxyphenethyl)-2,6-dimethoxyphenol

Research Excerpts

Overview

Chrysotoxine is a naturally occurring bibenzyl compound found in medicinal Dendrobium species.

ExcerptReferenceRelevance
"Chrysotoxine is a naturally occurring bibenzyl compound found in medicinal Dendrobium species. "( Chrysotoxine, a novel bibenzyl compound selectively antagonizes MPP⁺, but not rotenone, neurotoxicity in dopaminergic SH-SY5Y cells.
Shaw, PC; Song, JX; Sze, CW; Tang, CW; Tong, Y; Wong, NS; Yao, XS; Zhang, YB, 2012
)
3.26

Toxicity

ExcerptReferenceRelevance
" Given the different toxic profiles of 6-OHDA and MPP(+) as compared to rotenone, our results also indicated that DAT inhibition may partially account for the neuroprotective effects of chrysotoxine."( Chrysotoxine, a novel bibenzyl compound selectively antagonizes MPP⁺, but not rotenone, neurotoxicity in dopaminergic SH-SY5Y cells.
Shaw, PC; Song, JX; Sze, CW; Tang, CW; Tong, Y; Wong, NS; Yao, XS; Zhang, YB, 2012
)
2.01

Pharmacokinetics

ExcerptReferenceRelevance
" The method was successfully used to investigate the pharmacokinetic profile of CTX after oral (100 mg/kg) and intravenous (25 mg/kg) administration in rats."( Determination of chrysotoxine in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study.
Fan, J; Feng, F; Guan, L; Kou, Z; Liu, W; Zhang, Y, 2014
)
0.74

Bioavailability

ExcerptReferenceRelevance
" CTX showed rapid excretion and low bioavailability in rats."( Determination of chrysotoxine in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study.
Fan, J; Feng, F; Guan, L; Kou, Z; Liu, W; Zhang, Y, 2014
)
0.74
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID274760Antioxidant activity assessed by ORAC assay2007Journal of natural products, Jan, Volume: 70, Issue:1
Bioactive bibenzyl derivatives and fluorenones from Dendrobium nobile.
AID274762Cytotoxicity against murine RAW 264.7 cells by MTT assay2007Journal of natural products, Jan, Volume: 70, Issue:1
Bioactive bibenzyl derivatives and fluorenones from Dendrobium nobile.
AID274759Antioxidant activity assessed by DPPH radical scavenging assay2007Journal of natural products, Jan, Volume: 70, Issue:1
Bioactive bibenzyl derivatives and fluorenones from Dendrobium nobile.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.79 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]